GHI Grand Rounds: Cardiometabolic Therapies

Enduring CME will expire on 2/2/2024 Objectives: 1. Familiarize the audience with these new therapies and their impact in cardiovascular disease. 2. Describe the results of large prospective randomized clinical trial data utilizing these therapies to improve clinical outcomes. 3. To allow cardiologist to feel comfortable prescribing these drugs, originally developed to treat diabetes. Disclosures: - There is no commercial support for this activity - The speaker has disclosed the following financial relationships: - Advisory Board – Regeneron - Speaker Bureau – Boehringer Ingelheim, Amgen, and Esperion Accreditation and Designation: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Jaime Burkle MD, FACC, Non-invasive Cardiologist, Georgia Heart Institute

2/2/2022 12:00:00 PM